HIGH RESOLUTION NMR AND X-RAY CRYSTALLOGRAPHY SHARED RESOURCE Lorena Beese, Ph.D., and Leonard Spicer, Ph.D., Directors OVERVIEW The High Resolution NMR and X-ray Crystallography Shared Resource is designed to provide access to and technical support for state-of-the-art instrumentation essential for modern magnetic resonance spectroscopy and macromolecular crystallography. The resource is located on the ground floor of one wing of the recently built Levine Science Research Center and is conveniently accessible to members of the Duke Comprehensive Cancer Center from all units at Duke. The space was designed to house these facilities and provides an environment which encourages interaction among investigators due to proximity of individual instruments and common areas for seminars and informal gatherings as well as space for off line data processing. This Resource has three full time PhD level experienced staff members who are expert in NMR and X-ray techniques to train and assist users in both the fundamentals of these powerful technologies and also modern, advanced applications and methods. Websites have been established to provide information about the facilities and scientists in the resource and to encourage use of the resource. Through the organization and design of this integrated resource, we have assembled a team of experienced scientists to work closely with Cancer Center programs and projects to bring the full complement of NMR and X-ray approaches to bear on frontier research. Substantial effort and resources have been dedicated to enlarge and enhance the resource over the past five years in order to stay current with advancing technology. Over $3M in federal, private, and institutional funds have been spent for new equipment and upgrades for the Resource. New initiatives include full participation as a charter member of the recently constructed and commissioned Southeast Regional Collaborative Access Team (SER-CAT) crystallography station at the Advanced Photron Source at Argonne National Laboratory. This premier facility provides regular access to one of the worlds best synchrotron sources for X-ray crystallography. In addition, the NMR Center has been designated a node of the NIH supported 900 MHz NMR instrument resource to be installed at the University of Georgia. This provides access for Duke investigators to an NMR instrument operating at the highest field currently available commercially and one of the few such spectrometers in the world. The focus of the Duke collaboration with the University of Georgia is in developing and evaluating methods for studying large macromolecular complexes - an area of particular importance in NMR structural studies of cancer related biomolecular systems. Considerable momentum has been established with this resource over the recent years, and we have every expectation that it will continue to grow and provide outstanding benefit to cancer research at Duke. The resource is indispensable for the Cancer Center program in Structural and Chemical Biology. In addition, members of nine other programs routinely use the instrumentation in this resource or depend on data collected there. We have every expectation that use by Cancer Center members will continue to grow and are always looking forward to anticipate the needs associated with research projects within the Cancer Center.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-33
Application #
7726618
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2007-01-01
Budget End
2007-12-31
Support Year
33
Fiscal Year
2007
Total Cost
$148,275
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784
Dai, Ziwei; Mentch, Samantha J; Gao, Xia et al. (2018) Methionine metabolism influences genomic architecture and gene expression through H3K4me3 peak width. Nat Commun 9:1955

Showing the most recent 10 out of 513 publications